Clearpoint Neuro vs Iridex
Iridex is the larger business, with $52.7m of revenue in fiscal 2025 against $37.0m for Clearpoint Neuro (1.4 times as much). Clearpoint Neuro grew faster (17.8% against 8.2%). Iridex kept more of each dollar of sales as profit: a net margin of -8.4% against -69.1%.
| Latest fiscal year | Clearpoint NeuroCLPT, 2025 | IridexIRIX, 2025 |
|---|---|---|
| Revenue | $37.0m | $52.7m |
| Revenue growth | 17.8% | 8.2% |
| Net income | −$25.5m | −$4.4m |
| Operating margin | — | -4.9% |
| Net margin | -69.1% | -8.4% |
| Return on equity | -95.6% | -126.4% |
| Free cash flow | −$24.4m | −$2.3m |
| Cash | $45.9m | $6.0m |
| Total debt | $50.9m | $3.7m |
| Debt to equity | — | 75.9% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 172 | 93 |
| Market value | $310m | $12.7m |
| Price vs our value range | — | — |
| Moat score | 30 (Weak) | 34 (Weak) |
| Insider trades, 12 months | 0 buys, 9 sales | 83 buys, 0 sales |